Vasculitis: Understanding Autoimmune Inflammation of Blood Vessels

When your immune system turns against your own blood vessels, things can go wrong fast. Vasculitis isn’t just one disease-it’s a group of rare but serious conditions where your body’s defense system attacks the walls of your arteries and veins. This inflammation can narrow, block, or even rupture vessels, starving tissues of oxygen and leading to organ damage. It doesn’t care about age or lifestyle; it can strike a child with Kawasaki disease or an older adult with giant cell arteritis. And because symptoms often look like the flu, a bad cold, or arthritis, many people wait months before getting the right diagnosis.

How Vasculitis Works: The Immune System Goes Rogue

Your immune system is designed to protect you-from viruses, bacteria, and other invaders. But in vasculitis, it mistakes the lining of your blood vessels for something dangerous. The result? White blood cells swarm the vessel walls, causing swelling, scarring, and sometimes complete destruction. This isn’t just surface-level irritation. Inflammation in the media layer of muscular arteries can tear through the internal elastic lamina, a key structural layer. That’s what leads to aneurysms-bulging, weakened spots that can burst.

It’s not just one type of attack. Some forms cause tiny clots in capillaries. Others trigger granulomas-clusters of immune cells that form around vessels, especially in conditions like granulomatosis with polyangiitis (GPA). The damage depends on which vessels are targeted. If it’s the small vessels in your kidneys, you might not feel anything until your urine shows blood. If it’s the arteries feeding your brain, you could have sudden headaches, vision loss, or stroke-like symptoms.

Classifying Vasculitis by Blood Vessel Size

Doctors don’t treat all vasculitis the same. They group it by the size of the affected vessels-a system established by the Chapel Hill Consensus Conference and still used today.

Large-vessel vasculitis targets the aorta and its biggest branches. Giant cell arteritis (GCA) is the most common here, usually affecting people over 50. It often hits the temporal arteries near the temples, causing severe headaches, jaw pain when chewing, and sometimes sudden vision loss. Takayasu arteritis, less common, mostly affects younger women and can cause arm weakness or differences in blood pressure between arms.

Medium-vessel vasculitis includes polyarteritis nodosa (PAN) and Kawasaki disease. PAN affects muscular arteries in organs like the kidneys, liver, and intestines. It can cause abdominal pain, high blood pressure, or nerve damage. Kawasaki disease, on the other hand, is mostly seen in kids under 5. Without treatment, about 20-25% develop coronary artery aneurysms-making it a pediatric emergency.

Small-vessel vasculitis is where things get most complex. This group includes ANCA-associated diseases: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss). These are the ones most often linked to autoantibodies called ANCA. GPA typically affects the lungs and kidneys, with symptoms like coughing up blood, sinus infections, and kidney failure. MPA is similar but without the granulomas. EGPA adds asthma and high eosinophil counts into the mix.

What Symptoms Should Raise a Red Flag?

Vasculitis doesn’t come with a textbook symptom list. It mimics other illnesses-which is why diagnosis often takes 6 to 12 months. But certain patterns should make you or your doctor pause.

• Unexplained fever, weight loss, or fatigue lasting weeks
• Skin changes: purple or red spots, bumps, bruises, or clusters of tiny dots that don’t fade under pressure
• Joint or muscle pain that doesn’t respond to typical treatments
• Numbness, tingling, or weakness in hands or feet-signs of nerve damage
• Shortness of breath, coughing up blood, or chest pain
• Abdominal pain, diarrhea, or bloody stools
• Sudden vision changes or headaches, especially in someone over 50
• New-onset asthma or sinusitis in adults with unexplained systemic symptoms

Even if you feel mostly fine, vasculitis can quietly damage your kidneys. That’s why doctors always check urine for blood or protein and test kidney function-even if you have no symptoms. A simple blood test can reveal if your ESR or CRP is sky-high, which signals active inflammation.

How Is Vasculitis Diagnosed?

There’s no single test for vasculitis. Diagnosis is a puzzle made of four pieces: symptoms, blood tests, imaging, and biopsy.

Blood tests look for signs of inflammation: ESR over 50 mm/hr and CRP above 5 mg/dL are common. The big one is ANCA testing. c-ANCA (targeting proteinase-3) is 80-90% specific for GPA. p-ANCA (targeting myeloperoxidase) often points to MPA or EGPA. But ANCA can be negative in some cases-so a negative result doesn’t rule it out.

Imaging helps see where vessels are narrowed or blocked. CT scans, MRIs, or PET scans can show inflamed arteries in the chest, abdomen, or brain. For large-vessel vasculitis, ultrasound of the temporal arteries can reveal thickening or reduced blood flow.

Tissue biopsy remains the gold standard. If you have skin lesions, a biopsy of the rash can show leukocytoclastic vasculitis-characteristic debris from dying white blood cells around vessels. For kidney or lung involvement, a biopsy of the affected organ confirms inflammation and helps classify the type.

The Five Factor Score is used for polyarteritis nodosa to predict survival: if you have kidney, heart, or GI involvement, your risk goes up. But this score doesn’t apply to all types-each vasculitis has its own diagnostic criteria.

Treatment: From Steroids to Targeted Therapies

Early treatment saves organs. Delayed care can mean permanent kidney failure, blindness, or stroke.

For most severe cases, treatment starts with high-dose corticosteroids like prednisone-often 0.5 to 1 mg per kg of body weight daily. But steroids come with serious side effects: weight gain, bone loss, diabetes, mood swings. That’s why doctors now pair them with stronger drugs to get you into remission faster and reduce steroid exposure.

Induction therapy (the first few months) uses either cyclophosphamide or rituximab. Rituximab, which targets B-cells, has become preferred for many because it’s easier to tolerate and just as effective. For GPA and MPA, the 2022 ACR guidelines now include avacopan, a new pill that blocks a protein called C5a. In the ADVOCATE trial, patients on avacopan had 2,000 mg less cumulative steroid exposure over a year compared to those on prednisone alone.

Maintenance therapy lasts 18-24 months. Drugs like methotrexate, azathioprine, or continued rituximab help prevent relapses. About half of people with ANCA-associated vasculitis will have a flare within five years, so ongoing monitoring is critical.

For giant cell arteritis, steroids are still first-line-but now tocilizumab, an IL-6 inhibitor, is approved as an add-on. It lets patients taper steroids faster and reduces side effects. In Kawasaki disease, high-dose IV immunoglobulin and aspirin are used immediately to prevent heart damage.

And then there’s Buerger’s disease (thromboangiitis obliterans). This one’s different. It’s not autoimmune-it’s caused by smoking. The only treatment that works? Quitting tobacco. Everything else-meds, surgery, even amputation-fails if you keep smoking.

Prognosis and Long-Term Outlook

With proper treatment, 80-90% of people with ANCA-associated vasculitis go into remission. But remission doesn’t mean cure. Relapses happen. That’s why regular checkups-blood tests, urine tests, imaging-are part of life after diagnosis.

Survival rates vary. For polyarteritis nodosa without major organ damage, 5-year survival is 95%. If you have kidney or heart involvement, that drops to 50-75%. Kidney failure, heart attack, stroke, and lung bleeding are the biggest threats.

Children with Kawasaki disease who get treated early have excellent outcomes. But those who develop coronary aneurysms need lifelong cardiac monitoring. Adults with giant cell arteritis can live full lives-but they need bone density scans, eye exams, and blood sugar checks because of steroid use.

Research is moving fast. Trials are testing mepolizumab for EGPA and abatacept for GCA. Early results show relapse rates dropping by half in some cases. Scientists are also studying biomarkers like BAFF and MCP-1 in urine to predict flares before symptoms appear. The goal? Personalized treatment-knowing exactly when to step up or step down therapy.

What You Can Do

If you’ve been told you have vasculitis, your job isn’t just to take pills. It’s to become your own advocate.

• Know your type. Understand which vessels are affected and what organs are at risk.
• Track symptoms. Keep a log of fatigue, pain, rashes, or breathing changes.
• Never skip lab tests. Even if you feel fine, kidney and lung damage can sneak up.
• Ask about steroid-sparing options. Avacopan, rituximab, and tocilizumab can reduce long-term damage from steroids.
• Quit smoking-absolutely. If you have Buerger’s or even just any form of vasculitis, smoking makes everything worse.

Vasculitis is rare, but it’s real. And it’s treatable-if caught early. If you’ve had unexplained symptoms for months and no one’s found the cause, push for a rheumatologist. They’re the ones who see these patterns. They know what to look for. And they’re the ones who can stop the inflammation before it stops you.

Next Steps: What to Do If You Suspect Vasculitis

If you’re experiencing unexplained fatigue, skin rashes, nerve problems, or organ symptoms that don’t fit a common diagnosis, don’t wait. See your doctor. Ask for blood tests: ESR, CRP, ANCA, kidney function, and urine analysis. If those are abnormal or if symptoms persist, request a referral to a rheumatologist.

Don’t settle for "it’s just stress" or "you’re getting older." Vasculitis is rare, but it’s real-and treatable. Early action can prevent blindness, kidney failure, or stroke. Keep a symptom journal. Note when things started, what makes them better or worse, and any patterns. Bring it with you. Your story matters. And sometimes, the difference between a normal life and permanent damage is just a few weeks of early diagnosis.